C oCCidioides immitis is a dimorphic fungus endemic to arid regions of the southwestern US, northern Mexico, Central America, and South America. 10 An estimated 100,000 infections occur annually in the US, of which 34% are symptomatic. 10 The incidence of coccidioidal infection in Arizona has increased from 12 new cases per 100,000 people in 1995 to 58.2 new cases per 100,000 in 2005. 12 The primary clinical manifestation is acute respiratory infection caused by inhalation of airborne arthroconidia, which are deposited in the terminal bronchioles. In fewer than 5% of immunocompetent patients, coccidioidal infection evolves into disseminated extrapulmonary disease, commonly manifesting as meningitis, cutaneous and soft-tissue nodules, and fungal osteomyelitis. 12, 17 Treatment of the coccidioidomycosis of the spine is by no means routine. Although radiographically similar to bacterial osteomyelitis, coccidioidal osteomyelitis is an unrelenting disease, frequently resistant to medical management. Given the chronic nature of this disease, the standard rules for the treatment of infections afflicting the spinal column do not necessarily apply to this disease. Additionally, a current antibiotic regimen for this disease is not well established. Given the scarcity of data on the management of coccidioidomycosis involving the spine and the lack of guidelines for its treatment, data on its presentation, prevalence, and optimal treatment options, data from institutions treating this disease (frequently located in areas where the disease is endemic) are important for the clinical community that may not see this disease routinely. Although case reports of disseminated coccidioidomycosis of the spine have been reported, large series defining the patient population, demographics of the disease, and the role of surgery in conjunction with and as an adjunct to medical therapy are lacking. 6, 17 We present our experience with the surgical management of coccidioidomycosis of the spine at a single institution and discuss options for surgical and medical intervention. Object. Coccidioides immitis is a dimorphous fungus endemic in the southwestern US and northern Mexico. While its primary presentation is pulmonary, it can have devastating neurological sequelae.
Methods. The authors provide a retrospective review with long-term follow-up between 1986 and 2008 at a single institution.
Results. The authors identified 27 patients between 13 and 81 years old (mean 41.4 years) with spinal coccidioides who were treated surgically at the Barrow Neurological Institute between 1986 and 2008. There were 24 males (89%) and 3 females (11%). Eleven patients (41%) had cervical spine involvement, 15 (56%) had thoracic involvement, 7 (26%) had lumbar involvement, and 2 (7%) had sacral involvement. All 27 patients presented with localized or radiating pain. Nine patients (33%) had myelopathic symptoms at presentation, 5 (19%) had radiculopathy, 4 (15%) had fever, and 12 (44%) had progressive kyphosis. 
Methods

Patient Population
In a retrospective review, we identified 27 patients (24 male and 3 female) with spinal coccidioidomycosis treated surgically at the Barrow Neurological Institute between 1986 and 2008. Given our practice patterns as a major referral center for treatment of complex spinal pathology and the fact that most patients present with a diagnosis based on needle biopsy, it is difficult to estimate the exact number of patients who may have presented with spinal coccidioidomycosis who were treated using a medical regimen only. Patient age ranged from 13 to 81 years (mean 41.4 years). There were 14 African American, 3 Asian, 3 Hispanic, 5 Caucasian, and 2 other patients. All diagnoses were pathologically confirmed as coccidioidal infection. Clinical and hospital records, neuroimaging studies, and operative and pathology reports were available for all cases. Follow-up clinical notes and imaging studies were available for 19 (73%) of the 27 patients.
Results
Clinical Findings
All patients presented with localized or radiating pain. Several patients presented with a long-standing history of previously diagnosed coccidioidomycosis. Nine patients (33%) presented with myelopathic symptoms, 4 (15%) presented with fever, and 12 (44%) presented with progressive spinal deformity. Headache, sensory deficits, and paresthesias were also common symptoms (Table 1) . One patient experienced progressively worsening back pain for 3 days with deterioration to acute paraplegia immediately before presentation.
The diagnosis of coccidioidomycosis was confirmed on the basis of pathological specimens in all patients. Complement testing confirmed the diagnosis of coccidioidomycosis in 12 patients (44%), and Coccidioides immitis was identified in cultures from 10 sources (37%).
In every case, surgical management was combined with medical therapy using antifungal medications. The most frequent antifungal therapy consisted of monotherapy with voriconazole (30%), followed by fluconazole (26%) and amphotericin B (15%). In 5 (19%) of the 27 cases the organism was resistant to monotherapy, and polytherapy with multiple antifungal medications was necessary.
Imaging Studies
Plain radiographs and CT scans were obtained in all cases. Magnetic resonance imaging studies were available for 24 patients. Eleven patients (41%; 26 levels) presented with cervical spinal pathology, 15 (56%; 32 levels) with thoracic involvement, 7 (26%; 9 levels) with lumbar involvement, and 2 patients (7%; 2 levels) with sacral involvement. Two patients had extensive pathology disseminated among the cervical and thoracic regions. An epidural or paravertebral abscess was identified by MR imaging in 24 cases (89%).
Outcome and Complications
All 27 patients were treated with a combination of surgery and medical management. Follow-up was available for 19 of the 27 patients (mean follow-up 9.8 months, range 1-39 months). There were no identifiable complications related to surgery, 16 patients improved relative to their preoperative examination, while 1 remained stable, 1 worsened, and 1 died during the follow-up interval due to fulminant disease. Medical complications included 3 patients who were intolerant to amphotericin B therapy, 1 patient who was intolerant to voriconazole, and 3 patients who were resistant to fluconazole. All antifungal medications failed in 1 patient who was then placed on a regimen of chronic posaconazole therapy.
Illustrative Cases
Case 1
Presentation and Examination. This 48-year-old Asian American man was admitted through our emergency department with symptoms of neck pain, generalized weakness, fever, and sweats. An admission MR imaging study showed a 1.5-cm anterior fluid collection extending to the superior aspect of the dens and possibly extending into the C-2 vertebral body (Fig. 1A) , with an epidural abscess. A CT scan revealed osteolysis of the anterior arch of C-1 and likely osteomyelitis of C-1 and C-2 (Fig. 1B) .
Operation. Given the extension of the pathology to the vertebral body of C-2 and the chronic nature of the disease resulting in a Charcot joint, and the likelihood of instability, we elected to proceed to surgery for fusion. The patient underwent an Oc-C3 fusion with sublaminar wiring and iliac crest autograft (Fig. 1C) .
Postoperative Course. Postoperative analysis of the pathology revealed coccidioidomycosis with a titer of 1:10. The patient received amphotericin B and fluconazole. He suffered no surgical complications and was discharged to a skilled nursing facility. He made an excellent recovery and continues on a regimen of permanent antifungal therapy.
Case 2
Presentation and Examination. After transfer from an outside hospital, this 49-year-old African American man in a halo brace was admitted with symptoms of neck pain and radiographic evidence of occipitocervical instability. He had been diagnosed with systemic coccidioidomycosis 6 months before his transfer. Magnetic resonance images obtained at admission revealed an enhancing mass and granulation tissue in the occipitocervical region ( Fig. 2A) . There was no detectable epidural abscess. A CT scan revealed diffuse osteopenia and a pathological comminuted C-1 ring fracture with widening of the left lateral mass in relation to the C1-2 and Oc-C1 occiput articulations (Fig. 2B) .
Operation. Given the imaging-evident instability and the chronic nature of the coccidioidomycosis infection, a decision was made to proceed to the operating room for fusion. The patient underwent an Oc-C4 fusion with segmental instrumentation and auto-and allograft arthrodesis of Oc-C4 (Fig. 2C) .
Postoperative Course. Postoperative analysis of the pathology revealed coccidioidomycosis. The patient was started on a regimen of oral fluconazole and was discharged from the hospital on this regimen. The patient suffered no surgery-related complications and was discharged to a skilled nursing facility.
Case 3
Presentation and Examination. This 50-year-old African American man presented to our emergency department with back pain, numbness, and paresthesias in the perineal area with loss of bowel and bladder function. He had been diagnosed with systemic coccidioidomycosis 5 months before his presentation. Admission MR imaging showed a destructive enhancing lesion at T10-12 with minimal ventral epidural extension. There was notable kyphotic deformity at T10-11 without spinal cord compression (Fig. 3A) . There was no detectable epidural abscess. A CT scan showed destruction of the T10-12 vertebral bodies (Fig. 3B) .
Operation. Given the kyphotic deformity and extent of destruction, a decision was made to proceed to the op- erating room. The patient underwent an anterior corpectomy from T-10 to T-12 with T9-L1 fusion with auto-and allograft arthrodesis (Fig. 3C) .
Postoperative Course. Postoperative analysis of the pathology revealed coccidioidomycosis with a titer of 1:256. The patient received amphotericin B and fluconazole. Despite surgery, the patient continued to suffer from progressive destruction of the lower thoracic spine. The patient suffered no surgical complications and continued with antifungal therapy.
Discussion
Coccidioidomycosis is typically a mild disease that manifests with flu-like symptoms and a rash. 2 In rare cases of disseminated disease, the pathology can spread to the CNS and spine. Patients afflicted with AIDS may develop cerebral coccidioidomycosis, but spinal disease is rare. As is the case for all forms of coccidioidomycosis, patients should first undergo conservative medical treatment with antifungal medications. 2 
Medical Management of Coccidioidomycosis
The standard regimen used for the treatment of coccidioidomycosis is an "azole" antibiotic. Of the azole class of antibiotics, only ketoconazole is approved for the treatment of coccidioidomycosis by the US Food and Drug Administration. Although neither itraconazole nor fluconazole has been compared directly with ketoconazole, they are now commonly used in the treatment of coccidioidal infections based on recommendations from the Mycoses Study Group of NIAID (National Institute of Allergy and Infectious Diseases).
4,8
A randomized comparison of itraconazole and fluconazole in the treatment of progressive nonmeningeal coccidioidomycosis provides the most robust data on the choice of antibiotic regimen in treating this disease. 7 This trial suggests that fluconazole and itraconazole are equivalent for treating pulmonary and soft-tissue coccidioidomycosis. A small series suggests that itraconazole may be more potent than fluconazole for the treatment of skeletal lesions. 9 In an open-label study of 15 patients with chronic refractory coccidioidomycosis, posaconazole produced a complete response in 4 and a partial response in 7 patients. 16 A second study confirmed these findings in patients with chronic pulmonary or nonmeningeal disseminated coccidioidomycosis. 3 Voriconazole has had limited use in patients with refractory coccidioidomycosis. 1, 5, 13, 14 Current guidelines recommend that patients with disseminated infections should be treated with aggressive combined medical and surgical intervention. It is frequently difficult to determine when medical therapy has reached its limit and surgical intervention is necessary. The decision to proceed with surgery depends on the location and severity of the disease.
Surgical Management of Coccidioidomycosis
In refractory cases, nonresponsive to antibiotic regimens, surgical debridement may be necessary. Spinal column instability that may result in damage to the neuraxis if intervention is delayed is another indication for spinal surgery. Vertebrae are common sites for coccidioidomycosis osteomyelitis; however, determining which lesions will benefit from surgery is not always clear. Magnetic resonance images can be used to define the extent of lesions, 11 and radionuclide bone scans can identify areas of infection. 15 In certain cases vertebral lesions may be the only manifestation of disseminated diseases, suggesting that the disease may have a predilection for vertebral column.
In our series, there was a clear male predisposition for the disease-almost 90%. African Americans are the most commonly affected ethnic group, comprising more than 50% of the cases. Every patient in our series presented with symptoms of localized or radiating pain. The thoracic spine was the region most frequently affected, although cases also involved the cervical and lumbar spine. Our experience shows that spinal surgery can serve as an excellent adjunct to medical management by stabilizing the spine and preventing neurological compromise or deformity, which are related to incompetence of the spinal column. It is also important to note that, similarly to Pott disease, surgery and instrumentation may not be warranted in every case of spinal coccidioidomycosis. Our experience, however, suggests that most patients may require some form of surgical debridement and stabilization during the treatment of this disease, given the unrelenting and chronically antibiotic resistant nature of this disease. Patients who suffer from coccidioidomycosis of the thoracic spine may be treated by bracing and aggressive medical therapy alone, because the thoracic column is rigid, minimally mobile, and usually very stable. Indications for surgical intervention include neurological deficit, spinal instability, or intractable pain. Given the diffuse and incurable nature of the disease, surgical goals include decompressing the neural elements and stabilizing the spine. Ultimately, as with all infectious diseases, definitive therapy includes administering antifungal medications for the rest of the patient's life.
Conclusions
Our experience with surgical treatment of spinal coccidioidomycosis illustrates the utility of surgery as an adjunct to medical management of this rare disease. While spinal involvement of coccidioidomycosis is relatively uncommon, a high index of suspicion and aggressive therapy are warranted to prevent devastating neurological injury.
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